Literature DB >> 16376504

Small cell carcinoma of the larynx treated with irinotecan and cisplatin.

Michihiko Sone1, Ikue Uchida, Mitsuo Tominaga, Saiko Sugiura, Testuro Nagasaka, Tsutomu Nakashima.   

Abstract

We report a case of advanced small cell carcinoma in the larynx, which was treated with Irinotecan hydrochloride (CPT-11) chemotherapy. The patient was free of disease for 4 years after treatment. Several chemotherapeutic agents for small cell carcinoma have been proposed; however, median survival time has been miserable, especially in advanced cases. For the cure of the aggressive lethal behavior of this disease, chemotherapy with CPT-11 might be effective to improve median survival of patients with small cell carcinomas of the larynx.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16376504     DOI: 10.1016/j.anl.2005.09.002

Source DB:  PubMed          Journal:  Auris Nasus Larynx        ISSN: 0385-8146            Impact factor:   1.863


  2 in total

1.  [Poorly differentiated neuroendocrine carcinoma of the larynx. Diagnostic features, treatment strategy, and prognosis].

Authors:  M D Jumah; F Fleiner; S Wendt; M Pavel; M Schwabe; O Göktas
Journal:  HNO       Date:  2009-02       Impact factor: 1.284

2.  Small cell carcinoma of the tonsil treated with irinotecan and Cisplatin: a case report and literature review.

Authors:  Yuichi Segawa; Torahiko Nakashima; Hideki Shiratsuchi; Risa Tanaka; Kenji Mitsugi; Shizuo Komune
Journal:  Case Rep Oncol       Date:  2011-12-07
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.